BIAF insider transaction filings
bioAffinity Technologies, Inc. — 42 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-01-14. Screen BIAF transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for BIAF between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — bioAffinity Technologies, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-01-14 | 4 | Reveles Xavier Trinidad — Chief Operating Officer | Grant/award (A): 21,604 @ $0 | EDGAR |
| 2025-01-14 | 4 | Zannes Timothy P — Secretary, EVP, Gen. Counsel | Grant/award (A): 8,641 @ $0 | EDGAR |
| 2025-01-14 | 4 | Edwards James Michael — VP and CFO | Grant/award (A): 6,172 @ $0 | EDGAR |
| 2025-01-14 | 4 | Zannes Maria — President & CEO, Director | Grant/award (A): 37,037 @ $0 | EDGAR |
| 2025-01-14 | 4 | GIRGENTI STEVEN — Executive Chairman, Director | Grant/award (A): 14,814 @ $0 | EDGAR |
| 2024-11-05 | 4 | Edwards James Michael — VP and CFO | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2024-07-02 | 4 | Joyce Roby — Director | Grant/award (A): 33,784 @ $0 | EDGAR |
| 2024-07-02 | 4 | Anderson Robert A. — Director | Grant/award (A): 33,784 @ $0 | EDGAR |
| 2024-07-02 | 4 | Platt Jamie — Director | Grant/award (A): 33,784 @ $0 | EDGAR |
| 2024-07-02 | 4 | Zannes Maria — President & CEO, Director | Grant/award (A): 33,784 @ $0 | EDGAR |
| 2024-07-02 | 4 | Rubin Gary D — Director, 10% owner Harvey Sandler Revocable Trust — 10% owner | Grant/award (A): 33,784 @ $0 | EDGAR |
| 2024-07-02 | 4 | DIAMOND STUART — Director | Grant/award (A): 33,784 @ $0 | EDGAR |
| 2024-07-02 | 4 | KNIGHT PETER S — Director | Grant/award (A): 33,784 @ $0 | EDGAR |
| 2024-07-02 | 4 | GIRGENTI STEVEN — Executive Chairman, Director | Grant/award (A): 33,784 @ $0 | EDGAR |
| 2024-06-14 | 4 | Platt Jamie — Director | Grant/award (A): 8,296 @ $0 | EDGAR |
| 2024-06-14 | 4 | Joyce Roby — Director | Grant/award (A): 8,296 @ $0 | EDGAR |
| 2024-06-14 | 4 | Anderson Robert A. — Director | Grant/award (A): 8,296 @ $0 | EDGAR |
| 2024-06-14 | 4 | Zannes Maria — President & CEO, Director | Grant/award (A): 8,296 @ $0 | EDGAR |
| 2024-06-14 | 4 | Rubin Gary D — Director, 10% owner Harvey Sandler Revocable Trust — 10% owner | Grant/award (A): 8,296 @ $0 | EDGAR |
| 2024-06-14 | 4 | DIAMOND STUART — Director | Grant/award (A): 8,296 @ $0 | EDGAR |
| 2024-06-14 | 4 | KNIGHT PETER S — Director | Grant/award (A): 8,296 @ $0 | EDGAR |
| 2024-06-14 | 4 | GIRGENTI STEVEN — Executive Chairman, Director | Grant/award (A): 8,296 @ $0 | EDGAR |
| 2024-04-24 | 4 | Zannes Timothy P — Secretary, EVP, Gen. Counsel | Option exercise (M): 64,848 @ $1.16 · Tax withholding (F): 29,031 @ $2.58 · Option exercise (M): 64,848 (derivative) @ $0 | EDGAR |
| 2024-04-24 | 4 | Zannes Maria — President & CEO | Option exercise (M): 64,848 @ $1.16 · Tax withholding (F): 28,264 @ $2.65 · Option exercise (M): 64,848 (derivative) @ $0 | EDGAR |
| 2024-04-24 | 4 | GIRGENTI STEVEN — Director | Option exercise (M): 64,848 @ $1.16 · Tax withholding (F): 33,438 @ $2.24 · Option exercise (M): 64,848 (derivative) @ $0 | EDGAR |
| 2024-03-29 | 4 | Anderson Robert A. — Director | Option exercise (M): 64,848 @ $1.16 · Option exercise (M): 64,848 (derivative) @ $0 | EDGAR |
| 2024-03-29 | 4 | GIRGENTI STEVEN — Executive Chairman, Director | Grant/award (A): 39,474 @ $1.52 | EDGAR |
| 2024-02-02 | 4 | Zannes Timothy P — Secretary, EVP, Gen. Counsel | Grant/award (A): 6,688 @ $0 | EDGAR |
| 2024-02-02 | 4 | Reveles Xavier Trinidad — Chief Operating Officer | Grant/award (A): 16,720 @ $0 | EDGAR |
| 2024-02-02 | 4 | Rebel Vivienne I — Chief Sci. & Med. Officer, EVP | Grant/award (A): 31,847 @ $0 | EDGAR |
| 2024-02-02 | 4 | Dougherty Michael Philip — Chief Financial Officer | Grant/award (A): 31,847 @ $0 | EDGAR |
| 2024-02-02 | 4 | Zannes Maria — President, CEO, Director | Grant/award (A): 23,885 @ $0 | EDGAR |
| 2024-02-02 | 4 | GIRGENTI STEVEN — Executive Chairman, Director | Grant/award (A): 11,943 @ $0 | EDGAR |
| 2024-01-24 | 4 | Joyce Roby — Director Joyce Living Trust | Grant/award (A): 11,867 @ $1.58 · Grant/award (A): 12,668 @ $1.48 | EDGAR |
| 2024-01-24 | 4 | Platt Jamie — Director | Grant/award (A): 12,668 @ $1.48 | EDGAR |
| 2024-01-24 | 4 | Anderson Robert A. — Director | Grant/award (A): 11,867 @ $1.58 · Grant/award (A): 12,668 @ $1.48 | EDGAR |
| 2024-01-24 | 4 | Zannes Maria — President, CEO, Director | Grant/award (A): 11,867 @ $1.58 · Grant/award (A): 12,668 @ $1.48 | EDGAR |
| 2024-01-24 | 4 | Rubin Gary D — Director, 10% owner Harvey Sandler Revocable Trust — 10% owner | Grant/award (A): 11,867 @ $1.58 · Grant/award (A): 12,668 @ $1.48 | EDGAR |
| 2024-01-24 | 4 | DIAMOND STUART — Director | Grant/award (A): 11,867 @ $1.58 · Grant/award (A): 12,668 @ $1.48 | EDGAR |
| 2024-01-24 | 4 | Meghji Mohsin Y — Director | Grant/award (A): 11,867 @ $1.58 | EDGAR |
| 2024-01-24 | 4 | KNIGHT PETER S — Director | Grant/award (A): 11,867 @ $1.58 · Grant/award (A): 12,668 @ $1.48 | EDGAR |
| 2024-01-24 | 4 | GIRGENTI STEVEN — Executive Chairman, Director | Grant/award (A): 11,867 @ $1.58 · Grant/award (A): 12,668 @ $1.48 | EDGAR |
Recent 8-K events — bioAffinity Technologies, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-22 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-09 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-20 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BIAF returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →